princeton washington dc mexico bogota rio de janeiro basel johannesburg riyadh hong kong kybora...
TRANSCRIPT
Princeton Washington DC Mexico Bogota Rio de Janeiro Basel Johannesburg Riyadh Hong Kong
KYBORACompany BackgroundMay 2015
2 I
COM
PANY O
VERVIEW
Kybora is a global advisory firm focused on mergers and acquisitions, licensing, and commercialization of pharmaceutical products and medical devices. We distinguish ourselves by:
• Our global reach – We have offices in the US, Mexico, Brazil, Switzerland, Saudi Arabia, South Africa , and China. In addition, we have established strong partnerships Japan, Russia, and India, giving us access to strategic and financial investors located all over the world .
• The experience of our team – Our team combines over 300 years of business development experience in emerging markets. All of us have held senior level operational roles in the pharmaceutical and medical devices industries. We bring a unique perspective to our clients by understanding the operational challenges to being successful in emerging markets. Our worldwide network of relationships is unparalleled. We have access to decision makers which facilitates and accelerates transactions.
• Our areas of focus – We focus exclusively on life sciences transactions. We have had great success helping companies located in emerging markets sell themselves to strategic and financial investors located all over the world. We also help healthcare companies (Pharma, Biotech, Devices) maximize the value of their assets on a global basis through optimal licensing deals.
• Our engagement model - We pride ourselves for being honest, hard working, resilient, and dedicated to our clients. We seek to establish long-term relationships with our clients. Our engagement model is flexible and collaborative, providing our clients with a customized approach and intimate understanding of the pharma/biotech/medical devices decision-making process on a global scale.
We believe in the globalization of the healthcare market and in our ability to help our clients benefit in this evolving market landscape. We welcome the opportunity to work with you on your strategic needs.
3 I
GLO
BAL COVERAG
E
KYBORA - a company with global coverage:
KYBORA has offices in Princeton, Washington DC, Mexico City, Bogota, Rio de Janeiro, Basel, Johannesburg, Riyadh, and Hong Kong
In addition, KYBORA leverages well-established partnerships in Japan, India, Brazil, and Chile to provides its clients access to financial and strategic investors on a global basis
KYBORA offers the best combination of global reach and local knowledge.
JapanPartnered withDr. Newzella
IndiaPartnered withSathguru International
Basel
Princeton
Mexico City
Rio de Janeiro
Johannesburg
Hong KongRiyadh
Washington DC
Partnership with Biominas in Brazil
Partnership with Euro America in Chile
Bogota
4 I
COM
PANY O
VERVIEWOur Team
Alan Vanderborght, MBAManaging Director and CEO
18+ years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol- Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.
Dr. Ernesto Neumaan, MBA, Ph.D. Managing Director Latin America
40 + years career with Merck KGaA in Latam. General Manager in Argentina, Brazil, Ecuador, Colombia, Mexico, Peru, and regional VP Latam Merck Serono which had sales of $1.3 B and 2800 employees. During his tenure at Merck, Dr. Neumann realized more than 10 transactions. Merck Serono has the largest sales share in Latam of all multinational companies.
Nicolas Gikakis,MBAManaging Director Medical Device
18+ years of experience in the medical device and biotech fields. Global leadership positions at Pall, Terumo, and DSCP/Maquet, managing $200M business. Involved in several distribution, licensing, and M&A deals including the acquisition of brands from J&J, licensing of assets to Medtronic and Terumo, and integration of assets into existing commercial operations. Previous clinical and research background.
Ulrich Steuer,MBAManaging Director Mexico
30+ years of experience in the pharmaceutical industry in Latam. General Manager for Bristol-Myers Squibb in Mexico and Argentina. Prior to that Ulrich was Vice President Latin America Marketing and Business Development for Aventis where he was responsible for the launch of Lantus® in the region as well as many other products. He also held the position of GM Venezuela for Aventis.
Dr. Stephen Lee, Ph.D.Managing Director Asia Pacific
15+ years of experience in the life sciences sector. 7 + years working in Hong Kong and Asia. Founded and worked for start-ups (CASiGEN Pharma, TianXing Biopharmaceutical, LifeQual Pharmaceuticals) Experience in consulting, business development, fund raising (Ventac Partners, Bio-Enabler, 3V SourceOne Capital, Applied Strategies), and in equity research (First State Investments), and patent law (USPTO).
5 I
COM
PANY O
VERVIEWOur Team
Dr. Khalid Alkharfy,Pharm D., Ph.D.Managing Director Middle East and Africa
12 + years experience in pharmaceutical consultation, management, research, and product development Headed the Research Department of region's fourth generation science park - Riyadh Techno Valley where he was responsible for managing R&D activities. Managing Director of a biotechnology incubator in Riyadh, Saudi Arabia
Michal Bartos,MBAManaging Director Europe
35 years of experience in the pharma industry including CIBA-GEIGY/Novartis and Merck KGaA. Country Manager Italy and Czech Republic, Regional VP Central/Eastern Europe and Global Head Commercial Operations BU Fertility and Endocrinology. Vast BD experience with transactions in Switzerland, Portugal, Denmark, Central and Eastern European markets and in the Near and Middle East.
Francisco Hidalgo
Managing Director Latin America
34+ years of experience in the pharmaceutical industry in Latam. General Manager of Brazil, Mexico, Puerto Rico, Caribbean Region, Colombia, Regional VP for Central and South America, and VP of Global Mature Product Portfolio, Geographic Optimization and Footprint, Tactical Divestitures and Distributor Markets Working Group for BMS. VP and COO of Procaps Group.
Dr. Juan Camilo Palacio, MD, MBAAdvisor Latin America
25 years of experience in the life sciences sector in Latin America. Held several commercial leadership positions including CEO of Biotoscana, CEO of Lafrancol, President AstraZeneca Andean countries, General Manager Sanofi Brazil. Extensive M&A experience including the acquisition of Boots Pharma, Deutsch Pharma, OTC portfolio, and United Medical, and the divestiture of Lafrancol to CFR
Benjamin Vicuña, MBAAdvisor Medical Devices
20+ years of global experience in sales and marketing management, new business development and general management in the US, Europe and Latam with multinational companies including Johnson & Johnson, Boston Scientific and Healthpoint Biotherapeutics. Most recently he was General Manager for Latin America for Molnlycke Healthcare.
6 I
COM
PANY O
VERVIEWOur Team
Maurício GrimoniAdvisor Medical Devices Latin America
25+ years of experience in Med Dev and pharma in Brazil and LatAm. Country and LatAm manager for MNC and regional firms such as Bristol Myers Squibb, Merck Serono, Novartis, Janssen and Becton Dickinson. Managed and developed distribution networks. Economist with a MBA from PUC-São Paulo. Founded Latina Health Solutions, a specialized consulting company in Life Sciences for Latin America.
BK SinhaAdvisor Medical Devices India Asia
25+ years of experience in Med Device in India, Asia -PAC, MENA. Developed and managed extensive distributor networks for hospital products. Int’l manager for MNCs and regional firms, including Philips Medical Systems, Datascope Corp, USA and Eurocor. Extensive travel and strong connections with companies and Clinicians in MENA, Far East and Asia.
Dr. Oye Olukotun,MD, MPH, FACCAdvisor US
30 years experience in the pharma industry. CEO of Epigen Pharma and Vice Chairman of Cardiovax Inc., a biotech company developing innovative cardiovascular therapies. Co-founder and CMO of VIA Pharmaceuticals, CEO of of CR Strategies, LLC, a clinical research and development consulting firm, VP of Regulatory Affairs and CMO of Mallinckrodt, Inc., Director of diaDexus, Inc, past- Director of BioClinica, Nordion, & SemBiosys Genetics Inc.
Dan LiftonMBAAdvisor US
15 + years of experience in the nutraceutical industry. CEO of Quality of Life Labs. Recipient of 3 Nutracon Award for Scientific Achievement. President of the “Patented and Branded Products” division at Maypro. Worked at Deutsche Bank, Citigroup and Draper Fisher Jurvetson Gotham Ventures. Recipient of the “Most Promising MBA Entrepreneur of the Year” Award from Forbes magazine. Member of the American Society of Anti-Aging Medicine.
John GreggMBA, CLPAdvisor US
25 years experience in the pharma industry. CEO of BalinBac Therapeutics. Past CEO of Symbiomix Therapeutics and LifeQual Pharmaceuticals. Executive Director of Commercial Operations for AkaRx. Team Leader, Global New Products / Market Analytics at Pfizer. Worked in Anti-infectives, Dermatology, and Oncology groups at BMS, J&J, and Novartis. He began his career as a microbiologist, protein biochemist, and molecular biologist.
7 I
COM
PANY O
VERVIEWOur Services
Mergers and Acquisitions
Target Identification Valuation Preparation of Offers Due Diligence Negotiations Transition and
Integration Financing
Product Licensing and Distribution
Licensing Strategy Asset Screening Asset Positioning Partner Identification Contract Drafting Negotiations Transition services
Global Commercialization
Deliver Commercial Success Beyond Licensing
Commercialize New Products Successfully
Maximize Revenue of Existing Brands
8 I
ENG
AGEM
ENT M
OD
ELOur Engagement Model
Definition of
acquisition, divestiture or licensing
strategy
Valuation of
asset’s global
potential
Identification and
screening of
potential partners
Preparation of
positioning
material
Outreach and
selection of lead
partner(s)
Negotiation of Terms
and deal execution
CommercialLaunc
h
Kybora’s engagement model is flexible and collaborative. It can be customized to meet your specific objectives.
Our experienced resources will deliver immediate value to your organization at any point of the global merger, acquisition, divestiture, licensing, and commercialization spectrum.
We typically engage with a monthly retainer and a percentage of the consideration.
9 I
VALUE PRO
POSITIO
NKybora Value Proposition
Our team’s experience in the
global pharma and medical device
markets is unparalleled
No other boutique firm has the breadth
of our global coverage
We are a relationship based company. We pride ourselves on repeat business.
Each of our clients works with a
dedicated teamOur approach is
collaborative and adaptable to our
clients’ needs
We work directly with decision makers located all over the
world therefore facilitating and
accelerating the business
development process
10 I
CON
TACT INFO
RMATIO
NContact Us
PrincetonAlan [email protected]
+1 609 970 4398
Rio de JaneiroDr. Ernesto [email protected]
+55 212 434 5286
Mexico CityUlrich Steuer
[email protected]+52-155-1384-6361
Hong KongDr. Stephen Lee
[email protected]+852 6650 6402
Riyadh Dr. Khalid Alkharfy
[email protected]+ 966 562-99179
Washington DCNicolas Gikakis
[email protected]+1 516 702 0651
Basel Michal Bartos
[email protected]+41 79 593 17 33